← FDA Drug Approvals (Drugs@FDA)
BUPRENORPHINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN TECH VIATRIS · Approved 2021-05-03
Drug application
- FDA Application #
ANDA210162- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUPRENORPHINE
- Generic name
- Buprenorphine
- Active ingredients
- BUPRENORPHINE
- Dosage form
- FILM, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Marketing status
- Discontinued
- Sponsor
- MYLAN TECH VIATRIS
- First approval
- 2021-05-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown